European Biotechnology Week: latest developments in the sector
The European Biotech Week 2023 (European Biotech Week #EBW2023) with various events in the different [...]
Sep
David Bartel and microRNAs
David Bartel (Birmingham, 1958) is a leading researcher in molecular and cell biology who has [...]
Sep
Next most relevant congresses in the biotechnology sector
The biotechnology industry continues to grow and evolve, a good proof of this is the [...]
Sep
The wide range of job opportunities in the biopharmaceutical sector
The pharmaceutical industry is a constantly growing sector that plays a fundamental role in the [...]
Aug
The authorization process of a drug in Spain: phases and requirements
At OLIGOFASTX we are working to achieve solutions that improve the quality of life of [...]
Aug
The evolution of knowledge about RNA: from its discovery to the present day
RNA is an essential molecule for life, but its discovery and understanding has been a [...]
Aug
10 Practical Tips for Parents of Children Affected by Rare Diseases
In this article, practical advice for parents of children affected by rare diseases will be [...]
Jul
RNA Bibliography: a selection of the most influential publications in the field of biotechnology
RNA Bibliography: a selection of the most influential publications in the field of biotechnology In [...]
Jul
Innovation on the horizon: how big pharma investment is driving the development of oligonucleotide-based medicines
The mission of the OLIGOFATSX project is to develop oligonucleotide-based medicines to improve the quality [...]
Jun
Enzymes: key molecules for the development of oligonucleotides
The OLIGOFASTX team is focused on the development of oligonucleotide-based therapies for certain rare diseases [...]
Jun
From research to the public: the importance of clear and accessible science communication
Clear and accessible science communication is essential to bring research advances closer to the general [...]
Jun
Nanotechnology: a key tool for developing new drugs
Nanotechnology is a field that has revolutionised the pharmaceutical industry. The ability to manipulate materials [...]
Jun
Hope for patients with Fuchs’ Endothelial Corneal Dystrophy: Innovations in treatment
Today we talk in our blog about another of the rare diseases that the OLIGOFASTX [...]
May
The fight against cancer: past, present and future
The European Week Against Cancer 2023 will be held from May 25 to 31 with [...]
May
A day to recognize the role of clinical research: International Clinical Trials Day
May 20 marks International Clinical Trials Day, a date designed to highlight the importance of [...]
May
Computational Modeling in the service of health
Technological evolution is increasingly present in all areas of our lives. In today’s article we [...]
May
The experiment that helped crack the code of life
In 1961, Marshall Nirenberg and Heinrich Matthaei discovered the genetic code of living beings, which [...]
Apr
April 18: #EuropeanPatientsRightsDay
Today, the OLIGOFASTX team joins in the celebration of the European Patients’ Rights Day, a [...]
Apr
Alström syndrome: a rare disease with many comorbidities and complications
Rare diseases (affecting fewer than 1 in 2,000 people) are an emerging global public health [...]
Apr
Artificial Intelligence applied to the diagnosis and treatment of rare diseases
That Artificial Intelligence is coming to our daily lives is nothing new. We have all [...]
Mar
Tribute to Severo Ochoa, the Spanish biochemist who received the Nobel Prize for discovering the enzymes involved in RNA synthesis.
Of Spanish origin, the small and idyllic town of Luarca (Asturias) was the birthplace of [...]
Mar
Spanish pharmaceutical industry, third largest exporter with 53% growth to 2022
We love to share good news from the sector. On this occasion, we share the [...]
Mar
#8M, #InternationalWomensDay: “For an inclusive digital world”
One more year, we celebrate #InternationalWomensDay: a day that not only commemorates and pays tribute [...]
Mar
Rare Disease Day
Oligofastx is a project born from a need: to offer a therapeutic pathway based on [...]
Feb
Metaverse opens new opportunities for research and collaboration
If there is one word that distinguishes OLIGOFASTX and its philosophy, it is innovation. Thanks [...]
Feb
The contribution of women in science
Since 2015, the International Day of Women and Girls in Science has been celebrated every [...]
Feb
World Cancer Day
As it could not be otherwise, from Oligofastx we join in the celebration of the [...]
Feb
Leber Congenital Amaurosis
Leber’s congenital amaurosis (LCA) is an eye disease that primarily affects the retina, the inner [...]
Jan
A 2023 with a hopeful look at therapeutic oligonucleotides
The last few years have been a true revolution in terms of discoveries and initiatives [...]
Jan
Cancer cachexia
Cancer cachexia is a complex metabolic syndrome characterized by marked loss of body weight, anorexia, [...]
Jan
Providing solutions for rare diseases: a priority for the UN
Perhaps the definition is not the most accurate, but in reality a rare disease does [...]
Jan
Goodbye 2022, welcome 2023
In the last days of the year, it is time to review everything we have [...]
Dec
Innovative and sustainable production of biological molecules
The Oligofastx project covers all areas, from start to finish, of the process of developing [...]
Dec
Personalized treatments for rare diseases with oligonucleotides pose universal challenges
There is no doubt that oligonucleotide therapies aimed at providing answers and improving the quality [...]
Dec
Oligonucleotides, the language of life in small doses
A technological revolution can start with a key concept, the application of an equation or, [...]
Dec
Solid-phase synthesis in the amplification and sequencing of nucleic acids
The Oligofastx project covers the different phases of the development of oligonucleotide-based therapies, from design [...]
Nov
Oligonucleotides for curing osteoporosis, premature aging in children and hepatitis B
OLIGOFASTX follows with great interest all the recent advances in the work with oligonucleotides, not [...]
Nov
Maurice Wilkins, the third man of the double helix
History is peppered with stories, legends and tales. And as in all of them, any [...]
Nov
Anaplastic thyroid cancer: the most aggressive and lethal type of cancer
Thyroid cancer is a common malignancy of the endocrine system. There are four types: Papillary [...]
Oct
Guillain-Barré Syndrome: when the immune system attacks peripheral nerves
Today we are going to talk about one of those diseases classified as rare, for [...]
Oct
The Most Excellent Nobel Laureates 2022: these were the winners in the categories of Chemistry and Medicine
The work of the most renowned scientists, artists and diplomats is rewarded every year at [...]
Oct
Retinitis pigmentosa, a genetic vision pathology
Every last Sunday of September is celebrated the International Retinitis Pigmentosa Day, one of the [...]
Sep
Steinert’s myotonic dystrophy: when muscles become unresponsive
Today is International Myotonic Dystrophy Day, a rare disease with no treatment or cure to [...]
Sep
The OLIGOFASTX project is born
The project, subsidised by the CDTI with 5.4 million euros and a final budget of [...]
Jul